SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

383

Participants

Timeline

Start Date

November 26, 2012

Primary Completion Date

September 25, 2013

Study Completion Date

September 25, 2013

Conditions
Binge Eating Disorder
Interventions
DRUG

SPD489 (Lisdexamfetamine dimesylate)

50 or 70 mg administered orally, once-daily for up to 12 weeks

DRUG

Placebo

Administered once-daily, orally, for up to 12 weeks

Trial Locations (50)

10629

Ernovis GmbH, Berlin

11486

Sophiahemmet, Stockholm

11850

Stockholm Center for Eating Disorders, Stockholm

15206

Clinical Trials Research Services, LLC, Pittsburgh

19046

The Clinical Trials Center, LLC, Jenkintown

19063

Suburban Research Associates, Media

22152

Lakarmottagning Ekdahl & Kronberg, Malmo

22911

Charlottesville Medical Research Center, LLC, Charlottesville

23230

Alliance Research Group, Richmond

26655

Studienzentrum Nordwest, Gemeinschaftspraxis, Westerstede

27612

Wake Research Associates, LLC, Raleigh

28031

Hospital Universitario Infanta Leonor, Madrid

29464

Coastal Carolina Research Center, Mt. Pleasant

29621

Radiant Research, Inc., Anderson

32256

Clinical Neuroscience Solutions, Inc., Jacksonville

33161

Scientific Clinical Research Inc., North Miami

33319

Fidelity Clinical Research, Inc., Lauderhill

33912

Gulfcoast Clinical Research, Fort Myers

34748

Compass Research LLC, Leesburg

35216

Birmingham Research Group, Birmingham

38119

Clinical Neuroscience Solutions, Inc., Memphis

44130

North Star Medical Research, Middleburg Heights

45227

Community Research, Cincinnati

45417

Midwest Clinical Research Center, LLC, Dayton

46260

Goldpoint Clinical Research, LLC, Indianapolis

53562

Dean Foundation for Health, Research and Educations, Inc., Middleton

60169

Alexian Brothers Behavioral Health Hospital, Hoffman Estates

60563

AMR Baber Research, Inc., Naperville

60640

Uptown Research Institute, Chicago

63304

St. Charles Psychiatric Associates/Midwest Research Group, Saint Charles

67226

Cypress Medical Research Center, LLC, Wichita

72211

Clinical Study Centers, LLC, Little Rock

73103

IPS Research Company, Oklahoma City

75231

Futuresearch Trials of Dallas, L.P., Dallas

76309

Grayline Clinical Drug Trials, Wichita Falls

78731

Future Search Trials, Austin

80209

Western Affiliated Research Institute, Inc., Denver

84123

Radiant Research, Inc., Murray

87102

Pacific Research for Research and Evaluation, Albuquerque

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

90720

Pharmacology Research Institute, Los Alamitos

91316

Pharmacology Research Institute, Encino

92705

Research Across America, Santa Ana

92880

Trimed Clinical Trials, Corona

94812

Pacific Research Partners, LLC, Oakland

97301

Oregon Center for Clinical Investigations, Inc., Salem

98007

Northwest Clinical Research Center, Bellevue

02478

McLean Hospital, Belmont

05091

Neuropsychiatric Associates, LLC, Woodstock

01069

Klinische Forschung Dresden GmbH, Dresden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT01718483 - SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder | Biotech Hunter | Biotech Hunter